Clinical Development Asset Lead
argenx
About this role
The Clinical Development Asset Lead at argenx is responsible for guiding the clinical strategy for Adimanebart (ARGX-119), a monoclonal antibody program targeting neuromuscular diseases. The role supports multi-indication development across neurologic disorders and represents the asset within the Asset Strategy Team to inform its global development and commercial potential.
Skills
Qualifications
About argenx
argenx.comReaching Patients Through Immunology Innovation
Recent company news
Seeking AlphaArgenx SE: Excellent Company, Premium Valuation (NASDAQ:ARGX)
2 days ago
Yahoo FinanceAnalysts Express Mixed Opinion on Argenx SE (ARGX) Stock
4 days ago
Finviz - Stock ScreenerArgenx (ARGX) 2025 Net Product Sales Rise 90% to $4.2B as First Annual Profit Reached
3 days ago
Fierce PharmaOMG—argenx scores again with Vyvgart in ocular myasthenia gravis
2 weeks ago
Investing.comDeutsche Bank upgrades argenx stock to Buy on valuation appeal
1 day ago
About argenx
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for argenx.
Salary
$147k – $197k
per year
More jobs at argenx
Similar Jobs
Senior Director, Clinical Development
Insmed Incorporated
Associate Director (Supervisor) - Clinical Development
Eli Lilly and Company
Associate Director, Clinical Quality Assurance
Dyne Therapeutics
Medical Director, Clinical Development
Zymeworks
Director/Senior Director, Clinical Development
Systimmune
Executive Medical Director, Clinical Development, Pediatric Neurology
Neurocrine Biosciences